Competitive & Portfolio Intelligence · Compare
TrialMind vs Citeline Trialtrove+ vs Evaluate Pharma
Clinical trial intelligence tools, side by side. Pick any product to compare.
| TrialMindKeiji AIAI agents for trial intelligence | Citeline (Norstella)Curated clinical trial database | EvaluateForecasts and pipeline intelligence | |
|---|---|---|---|
| Best for | Custom landscapes and PoS estimates over a million linked trials, every claim sourced | Browsing a large curated trial database with enrollment benchmarks | Forecast-led questions: consensus sales tied to pipelines |
| Data | |||
| How the data is built | Registries, labels and papers, linked in TrialPanorama | Manually curated from 70,000+ sources2 | Not stated publicly3 |
| Trials | 1,060K+ | 555,000+2 | Not stated publicly3 |
| Drugs | 21K+ | Not stated publicly2 | ~6,000 with consensus forecasts3 |
| Conditions | 46K+ | 350+ diseases2 | Not stated publicly3 |
| Regulatory applications | 29K+ | Not stated publicly2 | Not stated publicly3 |
| Drug labels | 160K+ | Not stated publicly2 | Not stated publicly3 |
| Publications | 2,692K+ | Not stated publicly2 | Not stated publicly3 |
| Organizations | 254K+ | Not stated publicly2 | Not stated publicly3 |
| Investigators | 272K+ | Not stated publicly2 | Not stated publicly3 |
| Answers | |||
| Source link on every claim | Yes: Every claim links to its record | Not stated publicly2 | Partly: Citable answers from Evaluate data3 |
| Plain-language questions | Yes: Describe the task, review the plan | Yes: Ella AI assistant4 | Yes: Ask Ella AI analyst3 |
| Probability of success | Yes: By phase, with risk factors | Not stated publicly: Enrollment benchmarks instead4 | Yes: Product-specific PTRS5 |
| Published validation | Yes: Trial outcome prediction: HINT (Patterns), SPOT (ACM-BCB), Multi-modal generative AI (Patterns), TrialBench (Scientific Data) | Not stated publicly2 | Not stated publicly5 |
| Access | |||
| Delivery | SaaS, private cloud or your environment | Web platform plus Citeline analysts2 | Platform, feeds, APIs and MCP3 |
| API or MCP access | Yes: API and MCP | Not stated publicly2 | Yes: Selected APIs and MCP3 |
From each company’s public pages, checked 2026-10-21. A dash means the company does not say.
More comparisons
See TrialMind on your own question
A 30-minute walkthrough on a study like yours, with sources and code you can check.
Sources · checked 2026-10-21
Product details come from each company’s public pages. Spotted something out of date? Tell us and we will correct it.
- TrialMind: TrialPanorama
- Citeline Trialtrove+: citeline.com/products-services/trialtrove/
- Evaluate Pharma: www.evaluate.com/solutions/evaluate-pharma/
- Citeline Trialtrove+: www.citeline.com/en/plus
- Evaluate Pharma: www.biospace.com/evaluate-ltd-transforms-pharma-r-and-amp-d-risk-assessment-with-launch-of-product-specific-ptrs
- TrialMind: HINT (Patterns)
- TrialMind: SPOT (ACM-BCB)
- TrialMind: Multi-modal generative AI (Patterns)
- TrialMind: TrialBench (Scientific Data)